Schröder, Verena

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2015 | 2014 | 2013 | 2012 | 2010 | 2007 | 2006

2015

Handrková, Helena; Schröder, Verena; Kohler, H P (2015). The activation peptide of coagulation factor XIII is vital for its expression and stability. Journal of thrombosis and haemostasis, 13(8), pp. 1449-1458. Blackwell 10.1111/jth.13035

Jenny, Lorenz; Dobó, József; Gál, Péter; Schröder, Verena (2015). MASP-1 of the complement system promotes clotting via prothrombin activation. Molecular immunology, 65(2), pp. 398-405. Elsevier 10.1016/j.molimm.2015.02.014

Handrková, Helena; Borhany, M; Schröder, Verena; Fatima, N; Hussain, A; Shamsi, T; Kohler, H P (2015). Identification of two novel missense mutations causing severe factor XIII deficiency. Haemophilia, 21(3), e253-e256. Blackwell Science 10.1111/hae.12663

Jenny, Lorenz; Ajjan, Ramzi; King, Rhodri; Thiel, Steffen; Schröder, Verena (2015). Plasma Levels of MASP-1 and MASP-2 are Elevated in Type 1 Diabetes and Correlate with Glycaemic Control. Clinical and experimental immunology, 180(2), pp. 227-232. Blackwell Scientific Publications 10.1111/cei.12574

Schröder, Verena; Handrková, Helena; Dodt, Johannes; Kohler, Hans-Peter (2015). Free factor XIII activation peptide affects factor XIII function. British journal of haematology, 168(5), pp. 757-759. Wiley-Blackwell 10.1111/bjh.13144

Jenny, Lorenz; Dobó, József; Gál, Péter; Schröder, Verena (2015). MASP-1 Induced Clotting--The First Model of Prothrombin Activation by MASP-1. PLoS ONE, 10(12), e0144633. Public Library of Science 10.1371/journal.pone.0144633

2014

Dobó, József; Schröder, Verena; Jenny, Lorenz; Cervenak, László; Závodszky, Péter; Gál, Péter (2014). Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation. Molecular immunology, 61(2), pp. 69-78. Elsevier 10.1016/j.molimm.2014.05.013

Hess, Katharina; Alzahrani, Saad H; Price, Jackie F; Strachan, Mark W; Oxley, Natalie; King, Rhodri; Gamlen, Tobias; Schröder, Verena; Baxter, Paul D; Ajjan, Ramzi A (2014). Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Diabetologia, 57(8), pp. 1737-1741. Springer 10.1007/s00125-014-3267-z

2013

Borhany, M.; Handrkova, Helena; Cairo, A.; Schroeder, Verena; Fatima, N.; Naz, A.; Amanat, S.; Shamsi, T.; Peyvandi, F.; Kohler, Hans-Peter (2013). Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Haemophilia, 20(4), pp. 568-574. Blackwell Science 10.1111/hae.12340

Frauenknecht, Vera; Thiel, S.; Storm, L.; Meier, Niklaus; Arnold, Marcel; Schmid, Jean-Paul; Saner, Hugo; Schroeder, Verena (2013). Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. Clinical and experimental immunology, 173(1), pp. 112-120. Blackwell Scientific Publications 10.1111/cei.12093

Richardson, Victoria R.; Schroeder, Verena; Grant, Peter J.; Standeven, Kristina F.; Carter, Angela M. (2013). Complement C3 is a substrate for activated factor XIII that is cross-linked to fibrin during clot formation. British journal of haematology, 160(1), pp. 116-119. Oxford: Wiley-Blackwell 10.1111/bjh.12096

Boehlen, Françoise; Casini, Alessandro; Chizzolini, Carlo; Mansouri, Behrouz; Kohler, Hans Peter; Schroeder, Verena; Reber, Guido; de Moerloose, Philippe (2013). Acquired factor XIII deficiency: a therapeutic challenge. Thrombosis and haemostasis, 109(3), pp. 479-487. Stuttgart: Schattauer 10.1160/TH12-08-0604

Schroeder, Verena; Kohler, Hans Peter (2013). New developments in the area of factor XIII. Journal of thrombosis and haemostasis, 11(2), pp. 234-244. Oxford: Blackwell 10.1111/jth.12074

Schroeder, Verena; Kohler, Hans P. (2013). Factor XIII Deficiency: An Update. Seminars in thrombosis and hemostasis, 39(6), pp. 632-641. Thieme Medical Publishers 10.1055/s-0033-1353392

2012

Hess, Katharina; Ajjan, Ramzi; Phoenix, Fladia; Dobó, József; Gál, Péter; Schroeder, Verena (2012). Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation. PLoS ONE, 7(4), e35690. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0035690

Frauenknecht, V; Schroeder, V (2012). [Complement--a phylogenetically old system as a new player in the development of atherosclerosis]. Hämostaseologie, 32(4), pp. 276-85. Stuttgart: Schattauer 10.5482/ha-1191

Pasquier, E; De Saint Martin, L; Kohler, H P; Schroeder, V (2012). Factor XIII plasma levels in women with unexplained recurrent pregnancy loss. Journal of thrombosis and haemostasis, 10(4), pp. 723-5. Oxford: Blackwell 10.1111/j.1538-7836.2012.04657.x

Hess, K; Alzahrani, S H; Mathai, M; Schroeder, V; Carter, A M; Howell, G; Koko, T; Strachan, M W J; Price, J F; Smith, K A; Grant, P J; Ajjan, R A (2012). A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3. Diabetologia, 55(4), pp. 1103-13. Heidelberg: Springer 10.1007/s00125-011-2301-7

Castaman, G; Giacomelli, S H; Schroeder, V; Sanna, S; Valdrè, L; Morfini, M; Banov, L; Kohler, H P; Rodeghiero, F (2012). Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency. Haemophilia, 18(1), e6-8. Oxford: Blackwell Science 10.1111/j.1365-2516.2011.02622.x

Howes, Joanna-Marie; Richardson, Victoria R; Smith, Kerrie A; Schroeder, Verena; Somani, Riyaz; Shore, Anna; Hess, Katharina; Ajjan, Ramzi; Pease, Richard J; Keen, Jeffrey N; Standeven, Kristina F; Carter, Angela M (2012). Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes & vascular disease research, 9(3), pp. 216-25. London: Sage 10.1177/1479164111432788

2010

Schroeder, Verena; Ortner, Elisabeth; Mono, Marie-Luise; Galimanis, Aekaterini; Meier, Niklaus; Findling, Oliver; Fischer, Urs; Brekenfeld, Caspar; Arnold, Marcel; Mattle, Heinrich P; Kohler, Hans P (2010). Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study. Thrombosis research, 126(2), e122-7. Amsterdam: Elsevier 10.1016/j.thromres.2010.05.027

Schroeder, Verena; Kohler, Hans P (2010). Thrombelastographic studies on factor XIII. Thrombosis and haemostasis, 104(6), pp. 1277-9. Stuttgart: Schattauer 10.1160/TH10-06-0372

Ortner, Elisabeth; Schroeder, Verena; Walser, Reto; Zerbe, Oliver; Kohler, Hans P (2010). Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood, 115(24), pp. 5089-96. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-11-253062

Ivaskevicius, V; Biswas, A; Loreth, R; Schroeder, V; Ohlenforst, S; Rott, H; Krause, M; Kohler, H-P; Scharrer, I; Oldenburg, J (2010). Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia, 16(4), pp. 675-82. Oxford: Blackwell Science 10.1111/j.1365-2516.2010.02207.x

Ivaskevicius, Vytautas; Biswas, Arijit; Bevans, Carville; Schroeder, Verena; Kohler, Hans Peter; Rott, Hannelore; Halimeh, Susan; Petrides, Petro E; Lenk, Harald; Krause, Manuele; Miterski, Bruno; Harbrecht, Ursula; Oldenburg, Johannes (2010). Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica - the hematology journal, 95(6), pp. 956-62. Pavia: Ferrata-Storti Foundation 10.3324/haematol.2009.017210

2007

Zeerleder, Sacha; Schroeder, Verena; Lämmle, Bernhard; Wuillemin, Walter A; Hack, C Erik; Kohler, Hans Peter (2007). Factor XIII in severe sepsis and septic shock. Thrombosis research, 119(3), pp. 311-8. Amsterdam: Elsevier 10.1016/j.thromres.2006.02.003

Schroeder, Verena; Borner, Urs; Gutknecht, Stefan; Schmid, Jean-Paul; Saner, Hugo; Kohler, Hans P (2007). Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease. European journal of cardiovascular prevention & rehabilitation, 14(6), pp. 782-7. Los Angeles, Calif.: Sage 10.1097/HJR.0b013e32828622e8

Ivaskevicius, V; Windyga, J; Baran, B; Schroeder, V; Junen, J; Bykowska, K; Seifried, E; Kohler, H P; Oldenburg, J (2007). Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia, 13(5), pp. 649-57. Oxford: Blackwell Science 10.1111/j.1365-2516.2007.01517.x

Ivaskevicius, V; Seitz, R; Kohler, HP; Schroeder, V; Muszbek, L; Ariens, RA; Seifried, E; Oldenburg, J; Study, Group (2007). International registry on factor XIII deficiency: a basis formed mostly on European data. Thrombosis and haemostasis, 97(6), pp. 914-21. Stuttgart: Schattauer 10.1160/TH07-01-0034

Schroeder, Verena; Vuissoz, Jean-Marc; Caflisch, Amedeo; Kohler, Hans P (2007). Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thrombosis and haemostasis, 97(6), pp. 890-8. Stuttgart: Schattauer 10.1160/TH06-08-0458

2006

Schroeder, Verena; Meili, Esther; Cung, Trinh; Schmutz, Peter; Kohler, Hans P (2006). Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis, 95(1), pp. 77-84. Stuttgart: Schattauer 10.1160/TH05-06-0388

Zeerleder, Sacha; Schroeder, Verena; Hack, C Erik; Kohler, Hans Peter; Wuillemin, Walter A (2006). TAFI and PAI-1 levels in human sepsis. Thrombosis research, 118(2), pp. 205-12. Amsterdam: Elsevier 10.1016/j.thromres.2005.06.007

Provide Feedback